Radiogenomics in renal cancer management—current evidence and future prospects

M Ferro, G Musi, M Marchioni, M Maggi… - International journal of …, 2023 - mdpi.com
Renal cancer management is challenging from diagnosis to treatment and follow-up. In
cases of small renal masses and cystic lesions the differential diagnosis of benign or …

Renal cancer

U Capitanio, F Montorsi - The Lancet, 2016 - thelancet.com
The diagnosis and management of renal cell carcinoma have changed remarkably rapidly.
Although the incidence of renal cell carcinoma has been increasing, survival has improved …

The metabolic basis of kidney cancer

WM Linehan, LS Schmidt, DR Crooks, D Wei… - Cancer Discovery, 2019 - AACR
Kidney cancer is not a single disease but represents several distinct types of cancer that
have defining histologies and genetic alterations and that follow different clinical courses …

Papillary renal cell carcinoma (PRCC): an update

M Akhtar, IA Al-Bozom, T Al Hussain - Advances in anatomic …, 2019 - journals.lww.com
Papillary renal cell carcinoma (PRCC) is the second most common type of renal carcinoma
following clear cell renal cell carcinoma. Papillary renal cell carcinoma is usually divided …

Targeting the c-Met signaling pathway in cancer

B Peruzzi, DP Bottaro - Clinical cancer research, 2006 - AACR
On binding to the cell surface receptor tyrosine kinase (TK) known as c-Met, hepatocyte
growth factor (HGF) stimulates mitogenesis, motogenesis, and morphogenesis in a wide …

Hereditary kidney cancer syndromes

NB Haas, KL Nathanson - Advances in chronic kidney disease, 2014 - Elsevier
Inherited susceptibility to kidney cancer is a fascinating and complex topic. Our knowledge
about types of genetic syndromes associated with an increased risk of disease is continually …

Targeting the HGF/Met signaling pathway in cancer therapy

F Cecchi, DC Rabe, DP Bottaro - Expert opinion on therapeutic …, 2012 - Taylor & Francis
Introduction: Under normal conditions, hepatocyte growth factor (HGF)-induced activation of
its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine ligand …

Novel agents on the horizon for cancer therapy

WW Ma, AA Adjei - CA: a cancer journal for clinicians, 2009 - Wiley Online Library
Although cancer remains a devastating diagnosis, several decades of preclinical progress in
cancer biology and biotechnology have recently led to successful development of several …

Report from the international society of urological pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of …

SR Williamson, AJ Gill, P Argani, YB Chen… - The American journal …, 2020 - journals.lww.com
Renal cell carcinoma (RCC) subtypes are increasingly being discerned via their molecular
underpinnings. Frequently this can be correlated to histologic and immunohistochemical …

Genetic predisposition to kidney cancer

LS Schmidt, WM Linehan - Seminars in oncology, 2016 - Elsevier
Kidney cancer is not a single disease but is made up of a number of different types of cancer
classified by histology that are disparate in presentation, clinical course, and genetic basis …